NCT04121910 - A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

January 12, 2020

Study Completion Date

January 12, 2020

Conditions

Solid Tumour

Interventions

DRUG

Savolitinib

On Study Day 1 and Study Day 18, savolitinib will be administered as single dose after a high-fat, high-calorie breakfast

DRUG

Itraconazole

Twice daily on first day of dosing (Study Day 15) followed by once daily for 4 days (Study Day 16 - Study Day 19) administered 1 hour before any breakfast (and 1 hour before dinner on Study Day 15)

Trial Locations (1)

91206

Research Site, Glendale